02 November 2026

“Guardians of Patient Safety: The Critical Role of ADR Reporting in Dubai”

Reference: CIR-2026-00000203

“Guardians of Patient Safety: The Critical Role of ADR Reporting in Dubai”

To: All licensed health facilities within the jurisdiction and the scope of competence of Dubai Health Authority. 

The Dubai Health Authority (DHA) highly values the continued support and constructive cooperation of its partners across the healthcare sector.

As part of DHA’s commitment to enhancing the quality and efficiency of healthcare services, strengthening compliance, transparency, and accountability, and promoting awareness of the legislation and regulations governing the healthcare sector in the Emirate of Dubai, the Health Regulation Sector – Health Control Department – Drug Control Section is pleased to invite you to attend:

 “Guardians of Patient Safety: The Critical Role of ADR Reporting in Dubai”

The workshop will focus on Understanding the clinical necessity of Adverse Drug Reaction (ADR) reporting and identifying what, when, and how to report within the UAE regulatory framework. Aligning with global safety benchmarks, including the #MedSafetyWeek 2026 initiative.                                                 

Important Note:         
The workshop will be conducted in English. Healthcare facilities are therefore kindly requested to ensure the attendance of English-speaking representatives to enable full understanding and benefit from the workshop content.

 

Date: Tuesday, 3 November 2026
Time: 12:00 PM – 1:00 PM
Platform: Microsoft Teams
Attendance Link: 

Meeting-Join | Microsoft Teams

https://teams.microsoft.com/meet/343776483271631?p=5LVKArdfLxB5CMbyIs

 

We sincerely appreciate your continued support, cooperation, and commitment to regulatory compliance and to the ongoing enhancement of the quality and safety of healthcare services in the Emirate of Dubai.

 

Best Regards,

Health Control Department
Drug Control Section
Health Regulation Sector – Dubai Health Authority